CCDC170 and breast cancer: When cases in TCGA were stratified by subtype, CCDC170 mRNA levels were higher in the luminal A and luminal B subtypes, but were lower in the human epidermal growth factor receptor 2 (Her2)-positive and Basal-like breast cancer subtypes (Figure 1G).